article Open AccessTop 1% cited
Global trends in molecular epidemiology of HIV-1 during 2000–2007
AIDS · 2011 · Vol. 25(5) · pp. 679–689
Joris Hemelaar✉(University of Oxford)Eleanor Gouws(Joint United Nations Programme on HIV/AIDS)Peter D. Ghys(Joint United Nations Programme on HIV/AIDS)Saladin Osmanov(Joint United Nations Programme on HIV/AIDS)
Abstract
The global and regional distributions of individual subtypes and recombinants are broadly stable, although CRFs may play an increasing role in the HIV pandemic. The global diversity of HIV-1 poses a formidable challenge to HIV vaccine development.
HIV Research and TreatmentHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentCRFSSubtypingMolecular epidemiologyBiologyPandemicDistribution (mathematics)VirologyHuman immunodeficiency virus (HIV)EpidemiologyMedicine
MeSH terms
Cross-Sectional StudiesFemaleHumansMaleRecombination, GeneticSerotypingGenetic VariationGlobal HealthHIV-1HIV InfectionsMolecular Epidemiology
Funding
- National Institute for Health and Care Research
Citations
677
FWCI
34.31
field-weighted impact
References
27
Percentile
100%
vs. same field & year
Citations per year
References
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
AIDS · 2006 · 624 citations
Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand
The Journal of Infectious Diseases · 2006 · 825 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.